Length 154 pages

Date published September 2009

 Print copies are available upon request. Call 781-972-5444. 


 

For Corporate Subscriptions, Multi-Reports Orders, Discounts or Order Questions.  

Contact:
Kerri Kelley
Customer Service
781-972-1347 


IPR-Bundle-Button 

Ion Channel Modulator Pipelines: Targets and Agents in Development Overview

 

 

CoverIon Channel Modulator Pipelines: Targets and Agents in Development

Author: Peter Norman, PhD, MBA

 

 


 
Ion channels represent a significant opportunity to address an underexploited class of therapeutic targets. Nearly 150 novel ion channel modulators are reported to be in clinical development. This report examines: 

  • Ion channel modulators in clinical development and their potential 
  • Improved molecular understanding of ion channel structure and cellular activity 
  • High-throughput screening methods for identification of novel modulators 
  • Prospects for ion channel modulators and commercial successes to date• Pipeline activities, expert views, and survey results 
 

Ion Channel Modulator Pipelines: Targets and Agents in Development provides a comprehensive analysis of the ion channel modulator pipeline, breaking it down by company, ion channel type, and therapeutic indication. A number of interesting trends are revealed: Major pharmaceutical companies currently only account for just over one-third of all the ion channel modulators in development. The range of channel types targeted by ion channel modulators in development is relatively limited and heavily skewed toward a few channel types. Eighty percent of these ion channel modulators are being developed for diverse CNS indications. 

This report also analyzes the approximately 100 ion channel modulators that have been approved for clinical use. These drugs have generated considerable revenues: Even though generic forms of many of these agents are now available, sales of these branded drugs were around $20 billion in 2007. However, relatively few of these were developed using channel-based screening approaches, and many were identified with little or no knowledge of their mechanism of action. 

Table 

To date, ion channel modulators have been identified by various means, relatively few of which have so far been focused on direct screening of compounds for their activity on the channel(s) of interest. The past few years have seen significant developments that facilitate the identification of novel ion channel modulators. These improvements in screening methods should lead to more selective agents being identified and progressing into clinical development. We also examine other technical considerations when attempting to modulate ion channels, such as target distribution throughout the body, and the structure of ion channels and their multiple states (e.g., each state of the ion channel offers a different conformation for a potential ligand to recognize and thus any ion channel provides multiple potential targets). 

Ion Channel Modulator Pipelines: Targets and Agents in Development concludes with a commercial and scientific outlook, expert interviews, and results from a survey gauging trends, current practices, and views on ion channel-focused R&D activity. 

About the Author
Peter Norman, PhD, MBA, is a pharmaceutical consultant and analyst based in Burnham Beeches, near Windsor, England. He has written and presented widely on various aspects of respiratory disease, drug development, and on the analysis of diverse therapeutic markets. Dr. Norman has over 20 years of experience of the pharmaceutical industry in both R&D and competitive intelligence. His publications include many reviews and 16 original scientific papers and 11 patents, together with a number of management reports. The latter have been published by a number of companies including FT Pharmaceuticals, Urch Publications, SMI and Decision Resources, Informa, and Insight Pharma Reports (a division of Cambridge Healthtech Institute). Dr. Norman holds science degrees from Cambridge University and Brunel University and an MBA degree from the Open University.
 

 

Discovery on Target - Ion 


Affiliated Reports Collection 
 
Free Downloads